What is LOPJLB’s current signal on LUNG?

LOPJLB’s latest quantitative signal on Pulmonx Corporation (LUNG) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is LUNG in?

Pulmonx Corporation (LUNG) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Pulmonx Corporation (LUNG) do?

Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Complementing its therapeutic solutions, the company a…

Where is Pulmonx Corporation based / listed?

Pulmonx Corporation is based in US, listed on NASDAQ.

Pulmonx Corporation (LUNG)

COMPARE

Healthcare · Medical - Devices · NASDAQ · US

$1.84+1.66%Close

SELLRECOVERY · day 1

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $78M
Beta: 0.28
P/E (TTM): -1.55

Short % float: 2.17%
Days to cover: 3.2
SI change: -5.3%

1W: +0.55%
1M: -0.54%

vs SPY 1W: -0.61%
vs SPY 1M: -3.53%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Prediction markets

Company news